Research opens a window into understanding deadly brain tumors
- OPACC
- Dec 14, 2022
- 1 min read
Formerly known as diffuse intrinsic pontine gliomas, diffuse midline gliomas (DMGs) are highly aggressive tumors found in the midline of the brain. Their prognosis is very poor, in part because they don’t respond well to treatments such as chemotherapy and radiation. Now, research by Mariella Filbin, MD, PhD, and others in the Brain Tumor Center at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center has uncovered new details about how these rare tumors develop and grow that could someday inform specialized treatment options.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
Comments